Reference 2 - Criteria for waiver of evidence of in vivo bioavailability or bioequivalence
NonrulemakingSupporting & Related MaterialFDA-2026-P-6541-0004
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 9, 2026
- Agency
- Food and Drug Administration (FDA)